Precision Oncology and the PCR Pipeline: How Digital DNA Amplification is Transforming Cancer Survivability Rates
Liquid Biopsies and Minimal Residual Disease In the high-stakes world of oncology, timing is everything. The ability to detect a recurring tumor before it becomes visible on an MRI or CT scan is the holy grail of cancer treatment. Enter the "Liquid Biopsy," a PCR-based technique that screens a simple blood draw for Circulating Tumor DNA (ctDNA). Unlike traditional tissue biopsies, which are...
0 Σχόλια 0 Μοιράστηκε 26 Views 0 Προεπισκόπηση